ithetis_company.jpg

dedicated to preclinical research

Swissdesign – Swissresearch - Swisstechnology

Focus on high precision volumetric pump technology

Prof. Nikos Stergiopulos

Chairman and CSO

Nikos is Professor of Biomedical Engineering at the Swiss Federal Institute of Technology, Lausanne. He is co-inventor of the ithetis pump and a number of other devices (ARES, FloWatch etc.). Co-founder of EndoArt in 1998, a medical device company with world leader position in telemetric implants for congenital heart disease and obesity.

Olivier J. Vavasseur

CEO, Board member

Olivier holds a MBA from Duke University; he brings more than 15 years of international business experience with high-end specialized medical and consumer products. Olivier has managed numerous markets in Europe, USA and Asia. With Numico/Danone for 10 years, he has developed international business for the Clinical Nutrition Division and for the Baby Food Division.

Michel Bachmann

R&D Director, Board member

Michel holds a UAS diploma of engineer in Micromechanics. He developed numerous medical devices and he is a prolific inventor. Michel brings 20 years of experience in conceiving, designing and developing implantable devices (Wallstent™, Urolume™, Cavatherm™, EasyBand™, etc.). He is co-inventor of the ithetis pump.

 

© Swiss Federal Institute of Technology (EPFL)

Antlia SA is located at the PSE on the EPFL campus
(Lausanne, Switzerland)

ithetis is the world’s most advanced wirelessly controlled Implantable Drug Delivery Device. ithetis is developed to serve all preclinical and veterinary applications, where implantable micro pumps bring improved performance and treatments.